Sonoma Pharmaceuticals Inc (SNOA)

Überblick Nachrichten Preisverlauf Financials Warum fällt SNOA? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Sonoma Pharmaceuticals Inc

Healthcare (1087)

800-759-9305

5445 CONESTOGA COURT, SUITE 150, BOULDER, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SNOA's Discussions on Twitter

Compare SNOA vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SNOA Sonoma Pharmaceuticals Inc	1.34	6.37M	19.53M	-3.18M	-4.13M	-1.888
TAK Takeda Pharmaceutical Co Adr	18.27	58.50B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.88	42.84B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	40.68B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.50	30.40B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	497.22	21.36B	3.17B	1.29B	1.01B	27.09

Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten

Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Compare SNOA vs TAK, TEVA, HLN, ZTS, UTHR

Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten

Sonoma Pharmaceuticals Stock Price Forecast. Should You Buy SNOA? - StockInvest.us

Sonoma (SNOA) Market: Holds Near $1.34 in the Available Record; Current Setup: the Session Ends Within the Reported Technical Boundaries on the DayIV Contraction - vinanet.vn

Sonoma (SNOA) Market: Loses 0.75% to Close at $1.33; Key Range: Support at $1.26 and Resistance at $1.40 Frame the Range on the DayMid Cap Momentum - vinanet.vn

Sonoma (SNOA) Shares: Holds Near $1.34 at the Close; Technical View: the Session Ends Within the Reported Technical Boundaries in Latest TradingBear Flag - vinanet.vn

Form 8K Sonoma Pharmaceuticals Inc For: 19 August By Investing.com - Investing.com Nigeria

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com - Investing.com South Africa

Sonoma Pharmaceuticals Cancels Adjourned Special Stockholder Meeting - TipRanks

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum - Investing.com

Price to earnings forward of Sonoma Pharmaceuticals, Inc. – SWB:O8Z - TradingView

Sonoma Pharmaceuticals reports 60% revenue growth in Q1 By Investing.com - Investing.com Nigeria

Sonoma Pharmaceuticals reports 60% revenue growth in Q1 - Investing.com

Sonoma FY2027 Q1 earnings: 60% revenue growth moves EBITDA positive - TradingKey

Sonoma Pharmaceuticals Q1 revenue rises on US growth - TradingView

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA - Bay to Bay News

BRIEF-Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million - TradingView

Sonoma U.S. Revenue Climbs 141%; First-Ever Positive Adjusted EBITDA - Stock Titan

Sonoma Pharmaceuticals, Inc. Q1 2027: Revenue $6.41M, EPS $(0.09) — 10-Q Summary - TradingView

Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue - TradingView

Sonoma Pharmaceuticals (SNOA) Slides 5.83% to $1.13 as Key Support Level LoomsStop Loss Guidance - dars.gov.et

SNOA Q1'26 Earnings: EPS estimate is (0.30) USD - TradingView

SNOA Q2 2026 Earnings: Narrow EPS Miss Weighs on SharesROE Trend Analysis - vinanet.vn

Form DEF 14A SONOMA PHARMACEUTICALS For: 29 July By Investing.com - Investing.com Nigeria

Sonoma Pharmaceuticals (SNOA) Hovers Near Support as Slight Decline ContinuesRVOL Breakout - vinanet.vn

Sonoma Pharmaceuticals Inc (SNOA) Institutional Confidence - TradingKey

Sonoma Pharmaceuticals Inc (SNOA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Sonoma Pharmaceuticals Inc - TradingKey

SNOA|Sonoma Pharmaceuticals Inc|Price:1.140|Chg%:-0.020 - TradingKey

Sonoma Pharmaceuticals (SNOA) Slides 1.72% as Stock Holds Above Key Support at $1.08Time Weighted Price - dars.gov.et

TradingKey - TradingKey

SNOA Q2 2026 Earnings: Slight EPS Miss, Stock Edges LowerProfit Warning Alert - vinanet.vn

SNOA Q2 2026 Earnings: EPS Misses Estimates; Stock Rises Amid Operational UpdatesCFO Commentary Report - vinanet.vn

19,898 Common Stock of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 24-JUL-2026. - marketscreener.com

Sonoma Pharmaceuticals (SNOA) Edges Higher as Volume Patterns Suggest Accumulation Near Key SupportAAII Bearish - dars.gov.et

SNOA Q2 2026 Earnings: EPS Misses Estimates by 1.2%; No Revenue Reported, Stock UnchangedManagement Guidance Update - vinanet.vn

Sonoma Pharmaceuticals (SNOA) Holds Steady at $1.26 as Consolidation ContinuesInside Day Breakout - dars.gov.et

Enterprise value to revenue forward of Sonoma Pharmaceuticals, Inc. – NASDAQ:SNOA - TradingView

Form 4 Sonoma Pharmaceuticals Inc For: 9 July By Investing.com - Investing.com South Africa

Price to sales forward of Sonoma Pharmaceuticals, Inc. – NASDAQ:SNOA - TradingView

Sonoma Pharmaceuticals (NASDAQ: SNOA) awards CEO 10,000 RSUs in equity grant - Stock Titan

Enterprise value to EBIT forward of Sonoma Pharmaceuticals, Inc. – NASDAQ:SNOA - TradingView

Price to book forward of Sonoma Pharmaceuticals, Inc. – FWB:O8Z - TradingView

Price to sales forward of Sonoma Pharmaceuticals, Inc. – FWB:O8Z - TradingView

SNOA Should I Buy - Intellectia AI

Sonoma Pharmaceuticals (SNOA) Secures FDA Clearance for Microdac - GuruFocus

Sonoma Pharmaceuticals receives FDA clearance for wound solution - Investing.com

Sonoma Pharmaceuticals receives FDA clearance for wound solution By Investing.com - Investing.com Canada

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution - ACCESS Newswire

Sonoma Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:SNOA) - TradingView

Sonoma Pharmaceuticals Inc (SNOA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

SNOA Q1 2026 Earnings: EPS Misses Estimates by 1.2%, No Revenue Reported, Stock Edges Up 0.87% - po-news-eg.net

Sonoma Pharmaceuticals Expands At-the-Market Equity Offering Capacity - The Globe and Mail

Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SNOA